Bridger Management, LLC Rocket Pharmaceuticals, Inc. Transaction History

Bridger Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 14, 2019	SELL	$10.85 - $14.78 $13.5 Million - $18.4 Million	-1,247,366 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.81 $4.22 Million - $5.58 Million	-281,666 Reduced 18.42%	1,247,366 $18.7 Million
Q1 2019 May 15, 2019	SELL	$13.45 - $19.01 $3.01 Million - $4.26 Million	-223,870 Reduced 12.77%	1,529,032 $26.8 Million
Q2 2018 Aug 14, 2018	BUY	$14.58 - $23.0 $2.54 Million - $4.01 Million	174,333 Added 11.04%	1,752,902 $34.4 Million
Q1 2018 May 15, 2018	BUY	$11.68 - $19.19 $18.4 Million - $30.3 Million	1,578,569 New	1,578,569 $29.6 Million

244

108M

262K

159K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $664M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridger Management, LLC with notifications on news.